Pfizer, Moderna Face Continued Bayer mRNA Patent Fight as U.S. Judge Rejects Dismissal Bid

Bayer alleges the companies infringed its U.S. patent covering mRNA technology

Pfizer, BioNTech and Moderna will face continued legal action after a U.S. federal judge rejected their bids to dismiss Bayer’s patent lawsuits over mRNA technology used in their COVID-19 vaccines.

Bayer alleges the companies infringed its U.S. patent covering mRNA technology. The vaccine makers dispute the claims, but the judge ruled that their arguments did not justify dismissing the cases at this stage. The lawsuits will now proceed in federal court.